Hematology/Oncology

Top Story

University of Alabama at Birmingham appoints cancer center director

University of Alabama at Birmingham appoints cancer center director
June 24, 2017

Michael J. Birrer, MD, PhD, has been named director of University of Alabama at Birmingham Comprehensive Cancer Center.

Birrer’s appointment will be effective Aug. 1. He will succeed Edward E. Partridge, MD, who will retire from University of Alabama at Birmingham (UAB) after a 48-year career.

Meeting NewsVideo

VIDEO: Questions remain regarding use of gene-targeted therapy for lung cancer

June 23, 2017
CHICAGO — Suresh S. Ramalingam, MD, deputy director of Winship Cancer Institute of Emory University, discusses the results of a phase 3 trial that demonstrated…

10 updates in immunotherapy research

June 23, 2017
In recognition of Cancer Immunotherapy Month, Cancer Research Institute has organized a series of educational and social events designed to raise awareness regarding…
FDA News

FDA approves BevyxXa for prevention of venous thromboembolism

June 23, 2017
The FDA granted approval to betrixaban for the prevention of venous thromboembolism and pulmonary embolism in acutely ill patients who are not undergoing surgery…
In the Journals Plus

Midostaurin extends survival in acute myeloid leukemia with FLT3 mutation

June 23, 2017
The addition of midostaurin to standard chemotherapy improved OS and EFS among patients with acute myeloid leukemia and FLT3 mutation, according to results of the RATIFY…
More News Headlines »
CME

Polycythemia Vera: Aligning Real World Practices With Current Best Practices

This activity is supported by an independent educational grant from Incyte Corporation.

Ruben A. Mesa, MD, provides practical insights into treating polycythemia vera in this video series. In addition to…
More »
Video
Meeting News

VIDEO: Results of LATITUDE trial reinforce long-hypothesized theory in prostate cancer treatment

June 21, 2017
More »
Featured
ASCO Annual Meeting

ASCO Annual Meeting

CNE CME

The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement